Compare Nuwellis Inc (NUWE) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Snap On Incorporated — how do they compare? Nuwellis Inc trades at $2.84 (market cap $1.09M), while Snap On Incorporated trades at $402.3 (market cap $21.06B). The key difference: Snap On Incorporated is far larger — about 19321.1× Nuwellis Inc's market cap, and Snap On Incorporated pays a 2.4% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | SNA | |
|---|---|---|
Market Cap | $1.09M | $21.06B |
Sector | Technology | Technology |
52-Week High | $527.46 | $414.97 |
52-Week Low | $2.80 | $317.79 |
Enterprise Value | -$722.58K | $20.58B |
Dividend Yield | — | 2.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $3.00, up 5.26% today, following a 35:1 reverse stock split effective June 26, 2026. The company shows a low P/E of 0.06 and P/S of 0.01, but fundamentals are weak with a -217.22% net income margin and negative ROE. Recent news highlights patent awards and pediatric market expansion, yet cash flow remains negative. Analyst coverage is limited with a split buy/hold consensus.
Outlook is speculative; growth depends on successful commercialization of Aquadex therapy and cost management. Key risks include persistent losses, high cash burn, and competitive pressures. Investors should weigh low valuation against execution risks in the medical technology sector.
Snap-on Incorporated (SNA) trades at $406.53, down 1.09% on the day, near the consensus price target of $407.50. The stock shows a bullish technical trend with strong moving average signals and support at $403. Fundamentally, SNA maintains robust profitability with a 19.6% net income margin and 17.83% ROE, though Q1 2026 EPS slightly missed expectations. Recent acquisitions like Diesel Laptops for $100 million highlight strategic growth initiatives.
Outlook remains positive with 65% analyst buy ratings and a dividend yield supported by consistent cash flow. Key risks include margin pressures and muted revenue growth. The upcoming Q2 2026 earnings report on July 23, 2026, will be critical for validating current valuation multiples amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
